Skip to main content
Filing year 2024

The Jed Ian Taxel Foundation for Rare Cancer Research Inc

Park City, Utah·EIN 86-2610819·NTEE H30 · Medical Research·501(c)(3)
Total revenue
$309k
Total assets
$149k
Total expenses
$394k
Reported officers
13
Mission

To inspire and empower scientific breakthroughs, clinical trials and improved treatments which change lives and enable better outcomes for rare cancer patients and their families.

Executive compensation

Form 990 · Part VII & Schedule J · 1 reported individual · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.

President/ceo
10th to 25th percentile
$40k
$43k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the West region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 12 unpaid individuals.

Browse compensation in Medical Research

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at The Jed Ian Taxel Foundation for Rare Cancer Research Inc equaled 10% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
10%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

1
The Jed Ian Taxel Foundation for Rare Cancer Research Inc2024
$40k
2
INTERNATIONAL PLANT & HERBAL ALLIANCE2024
$30k
See full Executive Director compensation rankings across Medical Research
FAQ

Common questions about The Jed Ian Taxel Foundation for Rare Cancer Research Inc

What does the Chief Executive Officer of The Jed Ian Taxel Foundation for Rare Cancer Research Inc earn?

In 2024, the Chief Executive Officer of The Jed Ian Taxel Foundation for Rare Cancer Research Inc received $40,000 in total compensation. This pay is in the bottom quarter for Chief Executive Officer roles among Medical Research organizations nationwide, above the lowest 10% of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at The Jed Ian Taxel Foundation for Rare Cancer Research Inc compare with similar nonprofits?

Compared with the same role at Medical Research organizations nationwide, the 2024 pay of the Chief Executive Officer at The Jed Ian Taxel Foundation for Rare Cancer Research Inc falls between the 10th and 25th percentiles. In 2024, the highest total compensation at The Jed Ian Taxel Foundation for Rare Cancer Research Inc equaled 10% of the organization's total expenses. The median for medical research organizations is 10%.

What are The Jed Ian Taxel Foundation for Rare Cancer Research Inc's revenue and expenses?

In 2024, The Jed Ian Taxel Foundation for Rare Cancer Research Inc reported $309k in total revenue and $394k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.